Literature DB >> 29204189

Reversible splenial lesion syndrome (RESLES) coinciding with cerebral venous thrombosis: a report of two cases.

Jingyi Liu1, Dacheng Liu1, Bo Yang1, Jing Yan1, Yuehua Pu1, Jing Zhang1, Miao Wen1, Zhonghua Yang1, Liping Liu2.   

Abstract

A total of two postpartum women with no noteworthy medical history presented with persistent headache. Brain magnetic resonance imaging (MRI) of both revealed extensive cerebral venous thrombosis, concurrently with abnormal signals of the splenium of the corpus callosum (SCC): The splenium appeared hyperintense on T2-weighted sequences, fluid-attenuated inversion recovery (FLAIR), and diffusion-weighted imaging (DWI) imaging, and hypointense on T1 sequences and apparent diffusion coefficient (ADC) map. The patients were given thrombolytic therapy. Clinically, both patients achieved recovery with no neurologic sequelae, and follow-up MRI revealed complete resolution of the lesion in the SCC at day 36 and day 37 after initial presentation, respectively.

Entities:  

Keywords:  MRI; RESLES; cerebral venous thrombosis; splenium corpus callosum

Year:  2017        PMID: 29204189      PMCID: PMC5703104          DOI: 10.1177/1756285617727978

Source DB:  PubMed          Journal:  Ther Adv Neurol Disord        ISSN: 1756-2856            Impact factor:   6.570


Introduction

Reversible splenial lesion syndrome (RESLES) is a disorder characterized by the presence of a focal lesion often involving the central area of the splenium of the corpus callosum (SCC), followed by complete reversibility on follow-up magnetic resonance imaging (MRI) after a variable period of time. It is more commonly seen among patients with encephalitis or encephalopathy and among patients receiving antiepileptic drugs.[1] We report two cases of postpartum patients with cerebral venous thrombosis (CVT) concurrently presenting with an oval lesion of the SCC on MRI, hyperintense on T2-weighted and fluid-attenuated inversion recovery (FLAIR) sequences. The lesions appeared on the 10th and 4th day of initial onset, respectively, and remitted on the follow up 1 month later. Therefore, a diagnosis of RESLES was made. Additionally, we discuss the potential pathophysiological mechanism of RESLES, with respect to the results of previous studies. Treatment procedures for both patients were standard and in accordance with the Helsinki Declaration as revised in 2013. Both patients have given written consent for publication of their cases and imaging data in an international medical journal.

Case presentation

Patient 1

A 29-year-old woman presented with persistent right temporal parietal headache at 42 days postpartum. She had no noteworthy medical history and was not taking any medications. Neurological evaluation was unremarkable. Fundoscopy showed right papilledema. Blood electrolytes were unremarkable at onset. Computed tomography scan indicated “right temporal lobe hemorrhage”. She was admitted to local hospital. Initial MRI of the brain revealed a heterogeneous mixed signal of the right temporal lobe and abnormal enhancement of the right tentorial edge nodules. Treatment included lowering intracranial pressure, improving brain cell metabolism, and pain relief. During treatment, she had a temperature up to 99.5°F. Over several days, she experienced improvement of symptoms and a follow-up MRI (day 10 after onset) revealed “right temporal lobe hemorrhage surrounded by apparent swelling, right ventricle deformation due to compression, midline shift to the left, abnormal signal of the right transverse sinus and sigmoid sinus, hypointense on T1 sequence, hyperintense on T2 sequence, suspected cerebral venous thrombus. Abnormal signal of the SCC, right tentorial edge nodules”. Magnetic resonance venography scan showed no flow in the right transverse sinus and sigmoid sinus, suggesting intracranial venous sinus thrombosis. Brain MRI of the lesion in the SCC showed a round lesion, hyperintense on T2-weighted, FLAIR sequence, and diffusion-weighted imaging (DWI) imaging. It was hypointense on T1 sequence and the apparent diffusion coefficient (ADC) map, suggesting the presence of a cytotoxic edema (Figure 1). She was transferred to Beijing Tiantan Hospital Comprehensive Stroke Center for further treatment. Most laboratory tests were normal except D-dimer, which was elevated (4.6 μg/ml, normal < 1.5 μg/ml). The patient was treated with warfarin, mannitol, and prophylactic antiepileptic drugs. Symptoms soon remitted and she was discharged on day 19 after onset. After 2 weeks (total of 37 days after initial presentation) the patient had no neurologic sequelae, and a follow-up MRI revealed complete resolution of the lesion in the SCC.
Figure 1.

(a–h): There is no flow within the right transverse sinus and sigmoid sinus of the source image of magnetic resonance venography (MRV) (a). On T1-weighted image (b) the thrombus within the right transverse sinus is directly visualized as hyperintense clot. Brain MRI showing an oval lesion in the SCC, hyperintense on DWI (c) and T2-weighted (e), and hypointense on the ADC map (d). Sagittal T1W1 (f) displays the same lesion, with slight hypointense signal. Axial T2W1 (e) shows mixed intensity signal in the right temporal lobe, indicating venous thrombosis with secondary hemorrhagic infarct. In the follow up 2 weeks later, note the regression of hemorrhagic lesion in T2W1 (g). The abnormal signal in corpus callosum also remitted completely (g, h).

ADC, apparent diffusion coefficient; DWI, diffusion-weighted imaging; MRI, magnetic resonance imaging.

(a–h): There is no flow within the right transverse sinus and sigmoid sinus of the source image of magnetic resonance venography (MRV) (a). On T1-weighted image (b) the thrombus within the right transverse sinus is directly visualized as hyperintense clot. Brain MRI showing an oval lesion in the SCC, hyperintense on DWI (c) and T2-weighted (e), and hypointense on the ADC map (d). Sagittal T1W1 (f) displays the same lesion, with slight hypointense signal. Axial T2W1 (e) shows mixed intensity signal in the right temporal lobe, indicating venous thrombosis with secondary hemorrhagic infarct. In the follow up 2 weeks later, note the regression of hemorrhagic lesion in T2W1 (g). The abnormal signal in corpus callosum also remitted completely (g, h). ADC, apparent diffusion coefficient; DWI, diffusion-weighted imaging; MRI, magnetic resonance imaging.

Patient 2

A 27-year-old woman, in prior good health, started with a fever of 100.4°F 2 days postpartum. The pregnancy was without any symptoms or complications. At 7 days postpartum, she experienced headaches at the occipital and parietal area, with increased perspiration and left-sided numbness. Her mental state gradually deteriorated over the next several days. Blood electrolytes were unremarkable at onset. A brain MRI scan 4 days after onset indicated “Weak image signals of the inferior sagittal sinus, the left transverse sinus, sigmoid sinus, straight sinus and the torcular herophili, suspected cerebral venous thrombus. Abnormal signal of the SCC”. Magnetic resonance venography scan showed no flow in the inferior sagittal sinus, the left transverse sinus, sigmoid sinus, straight sinus and the torcular herophili, suggesting intracranial venous sinus thrombosis. The MRI showed a nonenhancing, rounded lesion of the SCC (Figure 2). A diffusion-weighted acquisition showed a hyperintense lesion corresponding to a decreased ADC. A lumbar puncture at day 5 after onset showed 14 leukocytes/μL, glucose level normal, pressure unknown. D-dimer levels were also elevated at 3.3 μg/ml. Her conditions improved in 2 weeks after receiving interventional thrombolytic therapy and further treated with heparin and warfarin. She was discharged with warfarin for further recovery at Beijing Rehabilitation Center. No special treatment was given on account of the lesion in the SCC. A follow-up MRI scan indicated the lesion in the SCC had completely resolved 1.5 weeks after discharge (total of 36 days after initial presentation).
Figure 2.

(a–h): There is no flow within the left transverse sinus, sigmoid sinus (a) and straight sinus (b) of the source image of DSA. An oval lesion is seen hyperintense on axial T2-weighted sequence (c) and DWI (d), hypointense on ADC map (e). The lesion completely remitted in the follow-up MRI (f–h) ten days later.

ADC, apparent diffusion coefficient; DWI, diffusion-weighted imaging; MRI, magnetic resonance imaging.

(a–h): There is no flow within the left transverse sinus, sigmoid sinus (a) and straight sinus (b) of the source image of DSA. An oval lesion is seen hyperintense on axial T2-weighted sequence (c) and DWI (d), hypointense on ADC map (e). The lesion completely remitted in the follow-up MRI (f–h) ten days later. ADC, apparent diffusion coefficient; DWI, diffusion-weighted imaging; MRI, magnetic resonance imaging.

Discussion

RESLES is a disorder involving transient lesions in the SCC.[1] It was first reported by Kim and colleagues[2] in 1999, describing a group of epileptic patients with concurrent corpus callosum lesions, deducing that these lesions may be caused by the use of the antiepileptic drug. Since then, there have been other cases of reversible lesions of the corpus callosum reported, but not entirely limited to patients using the antiepileptic drug. Japanese scholars Tada and colleagues[3] in 2004 first proposed the clinical symptoms associated with the corpus callosum lesions with reversible mild encephalitis/encephalopathy. Then Garcia-Monco and colleagues[4] proposed the concept of reversible corpus callosum lesion syndrome (RESLES) in 2011, and this concept has been in use ever since. RESLES is most commonly associated with seizures and antiepileptic drugs. Other factors include infections, metabolic conditions, other pharmacological agents, and miscellaneous conditions including anorexia nervosa, malnutrition, vitamin B12 deficiency, Charcot–Marie–Tooth disease, high-altitude cerebral edema, systemic lupus erythematosus (SLE), and eclampsia.[5] Clinical presentation is nonspecific, mainly related to the concurrent event, and most frequently presenting as an encephalopathy or encephalitis without evidence of callosal disconnection syndromes. The typical imaging presentation is a nonenhanced rounded or oval lesion in the splenium, hyperintense on T2WI and FLAIR sequence, isointense to slight hypointense on T1WI. DWI showed restricted diffusion with decreased ADC map values.[1,6] In certain cases, the lesion shows complete involvement of the splenium on diffusion-weighted image, otherwise known as the ‘boomerang sign’. The pathophysiology of RESLES is obscure. Many RESLES cases shows data supporting that intramyelinic cytotoxic edema plays an important role, as inferred by restricted diffusion on DWI and low ADC values.[1,7] Subsequent reversal of ADC values separates these lesions from persistent ischemia. However, it is reported that a neonate with asphyxia showed a reversible lesion on the SCC.[8] Considering myelination of the SCC is not completed in the first 2 months of a neonate, intramyelinic edema is unlikely the mechanism in that case. Antiepileptic drug toxicity and association with transhemispheric seizure propagation combined with changes in salt homeostasis and resultant myelin edema are other suggested mechanisms.[4,7] There are also some findings in hypoglycemia causing similar reversible lesions on MRI. A common mechanism has not yet been suggested because of the heterogeneous nature of etiologies. Generally, RESLES has an excellent prognosis, resulting in complete recovery without neurological sequelae after the acute disease course.[8] The results of previous studies indicate that severe disturbance of consciousness at onset, extracallosal lesions and diffuse slow waves on electroencephalogram (EEG) are indicative of a poor outcome.[9] MRI findings are expected to regress spontaneously within a few weeks to months. These are two of the few reported cases on RESLES in the setting of cerebral venous thrombosis (CVT). CVT is typically seen in young but otherwise previously healthy women. An abundance of predisposing factors of CVT has been identified. The most important ones are a prothrombotic state, commonly seen after routine intake of oral contraceptives, last trimester of pregnancy, puerperium, and ear, nose and throat infections.[10] The superior sagittal sinus and the transverse sinus are most commonly involved, frequently seen concurrently in a single patient. The predominant MRI findings for CVT are hyperintense parenchymal lesions on a T2-weighted image that involve white matter, gray matter, or both. Mark E Mullins and colleagues[11] did a retrospective study of parenchymal abnormalities associated with CVT, in which they noticed that CVT of the deep veins was associated with deep gray nuclei and deep white matter abnormalities, more commonly involving the thalamus, whereas superficial CVT was associated with cortical and subcortical lesions, often seen in frontal and parietal lobes. Both vasogenic and cytotoxic edema are thought to occur in the setting of CVT.[12] Increased venous pressure may lead to increased intracranial pressure, causing breakdown of the blood–brain barrier and vasogenic edema, or may cause severely decreased cerebral blood flow and cytotoxic edema. In the study, seven patients had lesions with elevated ADC values, most likely representing cytotoxic edema, that resolved on follow-up images. They hypothesize that revascularization of thrombosed veins or remodeling of collateral circulation can lead to a decrease in lesion volume, recovering vessel metabolism. Thus, cytotoxic edema associated with CVT may be reversible if the blood drains through collateral pathways.[13] In this sense, the reversible lesion in the SCC as seen in our two patients can be explained by the anatomical factors. The corpus callosum has a rich and complicated venous system. Venous drainage of the genu of corpus callosum is by anterior septal veins which are formed by a number of small veins; the two anterior septal veins unite near foramen of Monro and drain into internal cerebral veins, followed by posterior septal veins which also joins into the internal cerebral veins. The alternative drainage of anterior and posterior collosal veins along with numerous anastomotic small vessels give the corpus callosum sufficient circulatory compensation, allowing vessel recovery. Simone Appenzeller and colleagues reported an active SLE patient with focal transient lesions of the SCC also presenting with CVT on MRI.[14] However, the other two patients reported in the study are active SLE patients with SCC reversible lesions without the presence of CVT, indicating that SLE alone may also lead to RESLES, making the true etiology of the patient unclear. Therefore, to our knowledge, we are the first to report cases of CVT with concurrent RESLES. The specific mechanism of RESLES is unknown, however, the reversible pattern on DWI separates these lesions from persistent ischemia and venous sinus occlusion, where ADC reduction followed by reversal is uncommon.[1] Considering cytotoxic edema is known to occur in the setting of CVT, both patients had an initial MRI indicating cytotoxic edema in the SCC, and that anatomically the corpus callosum is capable of reversing cytotoxic edema, presenting with a reversible lesion in the MRI. Therefore, we consider cytotoxic edema to be the main mechanism for the two CVT patients to coincide with RESLES. Important etiological causes of splenial lesions in peripartum cases are sinus vein thrombosis, post-ictal state and preeclapmsia-eclampsia.[15] Takahashi and colleagues reported a rare case of RESLES with postpartum cerebral angiopathy.[16] The predilection for lesions in the SCC is unclear, but it may be related to its relative lack of pressure drop along the vessels, making it susceptible to edema in the setting of hypoxic cerebral vasodilatory circumstances.[17] The precise frequency of this syndrome is difficult to ascertain but it is likely underreported, given the time variability of appearance in imaging. Generally, the outcome appears to be completely reversible and necessitated no specific treatment or means of investigation other than a control brain MRI. In summary, clinicians should be aware that focal reversible lesions in the SCC may be seen in patients with CVT. Patients should be carefully investigated with MRI, including diffusion-weighted images and apparent diffusion coefficient value, and followed with repeated MRI to determine whether the presence of such lesions is transient. Further study of future cases may contribute to our understanding of RESLES.
  17 in total

1.  MRI findings of a postpartum patient with reversible splenial lesion syndrome (RESLES).

Authors:  Aysegul Altunkas; Fatma Aktas; Zafer Ozmen; Eda Albayrak; Ferdağ Almus
Journal:  Acta Neurol Belg       Date:  2015-12-21       Impact factor: 2.396

2.  Clinically mild encephalitis/encephalopathy with a reversible splenial lesion.

Authors:  Takashi Shiihara; Mitsuhiro Kato; Kiyoshi Hayasaka
Journal:  Neurology       Date:  2005-04-26       Impact factor: 9.910

3.  Neonate showing reversible splenial lesion.

Authors:  Jun-Ichi Takanashi; Masayuki Maeda; Masaharu Hayashi
Journal:  Arch Neurol       Date:  2005-09

4.  Reversible splenial lesion in postpartum cerebral angiopathy: a case report.

Authors:  Yoshinobu Takahashi; Naoya Hashimoto; Hiroki Tokoroyama; Shigeru Yamauchi; Matsuyoshi Nakasato; Kimito Kondo; Kazumi Nitta; Wataru Ide; Ikuo Hashimoto; Hajime Kamada
Journal:  J Neuroimaging       Date:  2012-08-28       Impact factor: 2.486

5.  Reversible splenial lesion with restricted diffusion in a wide spectrum of diseases and conditions.

Authors:  M Maeda; H Tsukahara; H Terada; S Nakaji; H Nakamura; H Oba; O Igarashi; K Arasaki; T Machida; K Takeda; J I Takanashi
Journal:  J Neuroradiol       Date:  2006-10       Impact factor: 3.447

6.  Parenchymal abnormalities associated with cerebral venous sinus thrombosis: assessment with diffusion-weighted MR imaging.

Authors:  Mark E Mullins; P Ellen Grant; Bing Wang; R Gilberto Gonzalez; Pamela W Schaefer
Journal:  AJNR Am J Neuroradiol       Date:  2004 Nov-Dec       Impact factor: 3.825

7.  Focal lesion in the splenium of the corpus callosum in epileptic patients: antiepileptic drug toxicity?

Authors:  S S Kim; K H Chang; S T Kim; D C Suh; J E Cheon; S W Jeong; M H Han; S K Lee
Journal:  AJNR Am J Neuroradiol       Date:  1999-01       Impact factor: 3.825

8.  Association of reversible splenial lesion syndrome (RESLES) with Anti-VGKC autoantibody syndrome: a case report.

Authors:  Thomas R Gilder; Jason S Hawley; Brett J Theeler
Journal:  Neurol Sci       Date:  2016-01-07       Impact factor: 3.307

9.  High-altitude cerebral edema evaluated with magnetic resonance imaging: clinical correlation and pathophysiology.

Authors:  P H Hackett; P R Yarnell; R Hill; K Reynard; J Heit; J McCormick
Journal:  JAMA       Date:  1998-12-09       Impact factor: 56.272

10.  Clinicoradiological spectrum of reversible splenial lesion syndrome (RESLES) in adults: a retrospective study of a rare entity.

Authors:  Shuo Zhang; Yan Ma; Juan Feng
Journal:  Medicine (Baltimore)       Date:  2015-02       Impact factor: 1.889

View more
  5 in total

1.  Anti-glial fibrillary acidic protein antibodies as a cause of reversible splenial lesion syndrome (RESLES): a case report.

Authors:  Kundian Guo; Xiaohui Lai; Yue Liu; Dong Zhou; Zhen Hong
Journal:  Neurol Sci       Date:  2021-06-05       Impact factor: 3.307

2.  Combining lexical and context features for automatic ontology extension.

Authors:  Sara Althubaiti; Şenay Kafkas; Marwa Abdelhakim; Robert Hoehndorf
Journal:  J Biomed Semantics       Date:  2020-01-13

3.  Reversible Splenial Lesion Syndrome with Some Novel Causes and Clinical Manifestations.

Authors:  Pei-Lin Lu; John F Hodes; Xu Zheng; Xing-Yue Hu
Journal:  Intern Med       Date:  2020-06-30       Impact factor: 1.271

4.  An Equivocal SCC Lesion-Antiepileptic-Induced CLOCC.

Authors:  Maryla Kuczyńska; Monika Zbroja; Weronika Cyranka; Izabela Halczuk; Ewa Kopyto; Iwona Halczuk; Anna Drelich-Zbroja
Journal:  Brain Sci       Date:  2022-03-13

5.  Is it coincidental or correlative between reversible splenial lesion syndrome and atrial septal defect?: A case report.

Authors:  Jiangang Li; Yingcong Chen; Jianxue Liu; Xingsheng Mai; Shaohua Jing
Journal:  Medicine (Baltimore)       Date:  2020-10-23       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.